Haibo Ni1, Alex Fogli Iseppe1, Wayne R Giles2, Sanjiv M Narayan3, Henggui Zhang4, Andrew G Edwards1, Stefano Morotti1, Eleonora Grandi1. 1. Department of Pharmacology, University of California, Davis, CA, USA. 2. Faculties of Kinesiology and Medicine, University of Calgary, Calgary, Alberta, Canada. 3. Division of Cardiology, Cardiovascular Institute, Stanford University, Stanford, CA, USA. 4. Biological Physics Group, School of Physics and Astronomy, The University of Manchester, Manchester, UK.
Abstract
BACKGROUND AND PURPOSE: Pharmacotherapy of atrial fibrillation (AF), the most common cardiac arrhythmia, remains unsatisfactory due to low efficacy and safety concerns. New therapeutic strategies target atrial-predominant ion-channels and involve multichannel block (poly)therapy. As AF is characterized by rapid and irregular atrial activations, compounds displaying potent antiarrhythmic effects at fast and minimal effects at slow rates are desirable. We present a novel systems pharmacology framework to quantitatively evaluate synergistic anti-AF effects of combined block of multiple atrial-predominant K+ currents (ultra-rapid delayed rectifier K+ current, IKur , small conductance Ca2+ -activated K+ current, IKCa , K2P 3.1 2-pore-domain K+ current, IK2P ) in AF. EXPERIMENTAL APPROACH: We constructed experimentally calibrated populations of virtual atrial myocyte models in normal sinus rhythm and AF-remodelled conditions using two distinct, well-established atrial models. Sensitivity analyses on our atrial populations was used to investigate the rate dependence of action potential duration (APD) changes due to blocking IKur , IK2P or IKCa and interactions caused by blocking of these currents in modulating APD. Block was simulated in both single myocytes and one-dimensional tissue strands to confirm insights from the sensitivity analyses and examine anti-arrhythmic effects of multi-atrial-predominant K+ current block in single cells and coupled tissue. KEY RESULTS: In both virtual atrial myocytes and tissues, multiple atrial-predominant K+ -current block promoted favourable positive rate-dependent APD prolongation and displayed positive rate-dependent synergy, that is, increasing synergistic antiarrhythmic effects at fast pacing versus slow rates. CONCLUSION AND IMPLICATIONS: Simultaneous block of multiple atrial-predominant K+ currents may be a valuable antiarrhythmic pharmacotherapeutic strategy for AF.
BACKGROUND AND PURPOSE: Pharmacotherapy of atrial fibrillation (AF), the most common cardiac arrhythmia, remains unsatisfactory due to low efficacy and safety concerns. New therapeutic strategies target atrial-predominant ion-channels and involve multichannel block (poly)therapy. As AF is characterized by rapid and irregular atrial activations, compounds displaying potent antiarrhythmic effects at fast and minimal effects at slow rates are desirable. We present a novel systems pharmacology framework to quantitatively evaluate synergistic anti-AF effects of combined block of multiple atrial-predominant K+ currents (ultra-rapid delayed rectifier K+ current, IKur , small conductance Ca2+ -activated K+ current, IKCa , K2P 3.1 2-pore-domain K+ current, IK2P ) in AF. EXPERIMENTAL APPROACH: We constructed experimentally calibrated populations of virtual atrial myocyte models in normal sinus rhythm and AF-remodelled conditions using two distinct, well-established atrial models. Sensitivity analyses on our atrial populations was used to investigate the rate dependence of action potential duration (APD) changes due to blocking IKur , IK2P or IKCa and interactions caused by blocking of these currents in modulating APD. Block was simulated in both single myocytes and one-dimensional tissue strands to confirm insights from the sensitivity analyses and examine anti-arrhythmic effects of multi-atrial-predominant K+ current block in single cells and coupled tissue. KEY RESULTS: In both virtual atrial myocytes and tissues, multiple atrial-predominant K+ -current block promoted favourable positive rate-dependent APD prolongation and displayed positive rate-dependent synergy, that is, increasing synergistic antiarrhythmic effects at fast pacing versus slow rates. CONCLUSION AND IMPLICATIONS: Simultaneous block of multiple atrial-predominant K+ currents may be a valuable antiarrhythmic pharmacotherapeutic strategy for AF.
Authors: Michael J Curtis; Steve Alexander; Giuseppe Cirino; James R Docherty; Christopher H George; Mark A Giembycz; Daniel Hoyer; Paul A Insel; Angelo A Izzo; Yong Ji; David J MacEwan; Christopher G Sobey; S Clare Stanford; Mauro M Teixeira; Sue Wonnacott; Amrita Ahluwalia Journal: Br J Pharmacol Date: 2018-04 Impact factor: 8.739
Authors: Ursula Ravens; Deniz Katircioglu-Öztürk; Erich Wettwer; Torsten Christ; Dobromir Dobrev; Niels Voigt; Claire Poulet; Simone Loose; Jana Simon; Agnes Stein; Klaus Matschke; Michael Knaut; Emre Oto; Ali Oto; H Altay Güvenir Journal: Med Biol Eng Comput Date: 2014-12-03 Impact factor: 2.602
Authors: Sébastien P J Krul; Wouter R Berger; Nicoline W Smit; Shirley C M van Amersfoorth; Antoine H G Driessen; Wim Jan van Boven; Jan W T Fiolet; Antoni C G van Ginneken; Allard C van der Wal; Jacques M T de Bakker; Ruben Coronel; Joris R de Groot Journal: Circ Arrhythm Electrophysiol Date: 2015-02-11
Authors: Marta González de la Fuente; Adriana Barana; Ricardo Gómez; Irene Amorós; Pablo Dolz-Gaitón; Sandra Sacristán; Felipe Atienza; Ana Pita; Ángel Pinto; Francisco Fernández-Avilés; Ricardo Caballero; Juan Tamargo; Eva Delpón Journal: Cardiovasc Res Date: 2012-10-11 Impact factor: 10.787
Authors: Haibo Ni; Alex Fogli Iseppe; Wayne R Giles; Sanjiv M Narayan; Henggui Zhang; Andrew G Edwards; Stefano Morotti; Eleonora Grandi Journal: Br J Pharmacol Date: 2020-08-09 Impact factor: 8.739
Authors: Stefano Morotti; Caroline Liu; Bence Hegyi; Haibo Ni; Alex Fogli Iseppe; Lianguo Wang; Marco Pritoni; Crystal M Ripplinger; Donald M Bers; Andrew G Edwards; Eleonora Grandi Journal: Sci Adv Date: 2021-11-17 Impact factor: 14.136